Joint Scientific Consultation Eligibility Criterion: Hubris or Naïveté
The eligibility criteria for Joint Scientific Consultation (JSC) raise important questions about the approach taken by the Member State Coordination Group on Health Technology Assessment (HTACG) [...]
Saved in:
| Main Authors: | Mondher Toumi, Bruno Falissard, Laurent Boyer, Pascal Auquier |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-05-01
|
| Series: | Journal of Market Access & Health Policy |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2001-6689/13/2/22 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical Trial Validity Guidance from the HTACG: Looking for Chicken Teeth
by: Mondher Toumi, et al.
Published: (2025-04-01) -
Welcome to the Journal of Market Access and Health Policy under MDPI Wings
by: Mondher Toumi
Published: (2024-01-01) -
Does Ceos Hubris Affecting Dividends Payout?
by: Kris Brantas Abipayu, et al.
Published: (2016-03-01) -
Gene therapies development: slow progress and promising prospect
by: Eve Hanna, et al.
Published: (2017-01-01) -
On the association between SARS-COV-2 variants and COVID-19 mortality during the second wave of the pandemic in Europe
by: Katarzyna Jabłońska, et al.
Published: (2021-01-01)